[18F]FE-PE2I DAT correlates with Parkinson’s disease duration, stage, and rigidity/bradykinesia scores: a PET radioligand validation study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
[18F]FE-PE2I DAT correlates with Parkinson’s disease duration, stage, and rigidity/bradykinesia scores: a PET radioligand validation study ; volume:13 ; number:1 ; day:5 ; month:4 ; year:2023 ; pages:1-10 ; date:12.2023
EJNMMI Research ; 13, Heft 1 (5.4.2023), 1-10, 12.2023
- Urheber
-
Kerstens, Vera S.
Fazio, Patrik
Sundgren, Mathias
Halldin, Christer
Svenningsson, Per
Varrone, Andrea
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13550-023-00974-7
- URN
-
urn:nbn:de:101:1-2023082121051240924321
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kerstens, Vera S.
- Fazio, Patrik
- Sundgren, Mathias
- Halldin, Christer
- Svenningsson, Per
- Varrone, Andrea
- SpringerLink (Online service)
Ähnliche Objekte (12)
![Microglial activation in Parkinson’s disease using [18F]-FEPPA](/assets/placeholder/searchResultMediaUnknown.png)
Microglial activation in Parkinson’s disease using [18F]-FEPPA
Proxy-analysis of the genetics of cognitive decline in Parkinson’s disease through polygenic scores
Development of a novel radioligand for imaging 18-kD translocator protein (TSPO) in a rat model of Parkinson’s disease
Reliability of dopamine transporter PET measurements with [18F]FE-PE2I in patients with Parkinson’s disease
Parkinson
Parkinson
Objective measurement in Parkinson’s disease: a descriptive analysis of Parkinson’s symptom scores from a large population of patients across the world using the Personal KinetiGraph®
The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson’s disease
Evaluation of the PREDIGT score’s performance in identifying newly diagnosed Parkinson’s patients without motor examination
18F-AV-1451 in Parkinson’s Disease with and without dementia and in Dementia with Lewy Bodies
Occipital hypoperfusion and motor reserve in Parkinson’s disease: an early-phase 18F-FP-CIT PET study
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Microglial activation in Parkinson’s disease using [18F]-FEPPA
Proxy-analysis of the genetics of cognitive decline in Parkinson’s disease through polygenic scores
Development of a novel radioligand for imaging 18-kD translocator protein (TSPO) in a rat model of Parkinson’s disease
Reliability of dopamine transporter PET measurements with [18F]FE-PE2I in patients with Parkinson’s disease
Parkinson
Parkinson
Objective measurement in Parkinson’s disease: a descriptive analysis of Parkinson’s symptom scores from a large population of patients across the world using the Personal KinetiGraph®
The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson’s disease
Evaluation of the PREDIGT score’s performance in identifying newly diagnosed Parkinson’s patients without motor examination
18F-AV-1451 in Parkinson’s Disease with and without dementia and in Dementia with Lewy Bodies
Occipital hypoperfusion and motor reserve in Parkinson’s disease: an early-phase 18F-FP-CIT PET study
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Microglial activation in Parkinson’s disease using [18F]-FEPPA
Proxy-analysis of the genetics of cognitive decline in Parkinson’s disease through polygenic scores
Development of a novel radioligand for imaging 18-kD translocator protein (TSPO) in a rat model of Parkinson’s disease
Reliability of dopamine transporter PET measurements with [18F]FE-PE2I in patients with Parkinson’s disease
Parkinson
Parkinson
Objective measurement in Parkinson’s disease: a descriptive analysis of Parkinson’s symptom scores from a large population of patients across the world using the Personal KinetiGraph®
The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson’s disease
Evaluation of the PREDIGT score’s performance in identifying newly diagnosed Parkinson’s patients without motor examination
18F-AV-1451 in Parkinson’s Disease with and without dementia and in Dementia with Lewy Bodies
Occipital hypoperfusion and motor reserve in Parkinson’s disease: an early-phase 18F-FP-CIT PET study